Everardo Saad is a medical oncologist with a special interest in clinical-trial methodology. A native from Brazil, he graduated in Medicine and trained in Internal Medicine in Sao Paulo, and later pursued a fellowship in Medical Oncology at the University of Texas M.D. Anderson Cancer Center, in Houston, USA. After several years of clinical practice, he shifted his career toward the methodology of clinical research. He has over 15 years of experience in design and analysis of clinical trials for pharmaceutical/biotech companies and academic groups.
Now based in Brussels, he serves as Medical Director and as a member of the team of consultants at IDDI, a company that provides services related to data management, statistics, and randomization. He has published more extensively in the area of efficacy endpoints in oncology.